Chronic arsenic (As) poisoning has been widely reported in the general population in many areas of the world. Arsenic exposure occurs by consumption of drinking water that naturally contains high amounts of inorganic forms of As. [1] In West Bengal, India, a large population is endemically exposed to inorganic As by drinking heavily contaminated groundwater through hand-pumped tubewells. [2] Exposure to As may cause severe biochemical and pathological problems such as Blackfoot disease, [3] hypertension, [4] diabetes mellitus [5] and cancers of the liver, kidney, lung and bladder in humans. [6] Data is also available for the toxic effects of As on whole brain [7, 8] and in discrete regions [9, 10] of rats and mice. Recent studies have suggested that As exerts its toxicity through the generation of reactive oxygen species (ROS), [11] [12] [13] which include hydrogen peroxide and free radicals such as superoxide anions. Free radicals have previously been shown to be capable of damaging many cellular components such as DNA, [14] proteins [15] and lipids. [16] In addition, sodium arsenite has been shown to enhance heme oxygenase production, an indicator of oxidative stress. [17] ROS participate in the induction of oxidative stress. Arsenicals can produce ROS in vitro [18] [19] [20] [21] [22] and in vivo.
[23] Most of these reports mentioned that ROS levels increased by arsenicals were suppressed by the addition of various scavengers for ROS or enzymatic antagonists of superoxide and hydrogen peroxide production, suggesting that hydroxyl radicals are produced through hydrogen peroxide resulting from superoxide.
The clinical choice for the treatment of arsenic poisoning is the administration of a sulfhydryl-containing chelator such as meso-2,3-dimercaptosuccinic acid (DMSA), 2,3-dimercaptopropane-1-sulfonate (DMPS) or British Anti Lewisite (BAL; 2,3-dimercaprol). These dimercapto chelators compete with sulfhydryl groups in tissues or enzymes for binding As (III) , which results in the elimination of As. DMSA, a dithiol and an orally administered chelator belonging to the mercapto family has a vicinal thiol moiety which binds arsenic. Thus, it is a potentially useful drug for the treatment of arsenic poisoning [24, 25] and has the structural potential to serve as an antioxidant in vivo. [26] A new trend in chelation therapy has emerged, which is to use combination therapy instead of monotherapy with individual chelating agents. [27] Co-administration of antioxidants such as vitamins C and E [28, 29] or N-acetyl cysteine [11] and some essential metals such as zinc [30] during chelation therapy has been found to be beneficial in increasing arsenic mobilization and assisting the recovery selenite were prepared immediately before use. The dosing of altered biochemical variables. Oxidative stress is one of the volume amounted to 4 ml/kg body weight. important mechanisms of arsenic-induced toxicity. Thus, it is Animals and treatments expected that co-administration of an antioxidant like Se may All experiments were performed on male Wistar rats, each be an important component of an effective chelation therapy.
weighing approximately 100-120 g. Animals were obtained from Selenium, an essential trace element for humans, is an essential the animal house facility of Defence Research and Development component of glutathione peroxidase (GPx), an antioxidase Establishment (DRDE), Gwalior. The Animal ethical committee enzyme, which plays a critical role in the body's antioxidant of DRDE, Gwalior, India approved the protocols for the defense against oxidative damage by preventing the production experiments. Prior to dosing, they were acclimated for seven of ROS. [31, 32] This enzyme together with superoxide dismutase days to light from 06:00 to 18:00 h alternating with 12 h (SOD), catalase and vitamin E neutralize ROS.
darkness. The animals were housed in stainless steel cages The interaction of Se with various metals produces protective (five rats/cage) in an air-conditioned room with temperature effects in vitro and in vivo. [28, [33] [34] [35] Arsenic and selenium are maintained at 25 ± 2 º C. Rats were allowed standard rat chow metalloids with similar chemical properties but with markedly diet (Amrut Feeds, Pranav Agro, New Delhi, India; Metal contents different biological effects, Se being known to offer protection of diet in ppm, dry weight: Cu 10.0, Zn 45.0, Mn 55.0, Co 5.0, Fe against arsenic toxicity. [36, 37] Protection against liver and kidney 75.0) and water ad libitum throughout the experiment. damage by Se was shown to be a result of enhanced antioxidant Thirty male Wistar rats were divided into two groups of capacity of cells, as evidenced by increased SOD and glutathione five (control, group I) and twenty-five rats (group II) and were reductase (GR) activities and elevated glutathione (GSH) content. [38] administered normal water (group I) and 100 ppm sodium Sodium selenite and selenomethionine were reported to protect arsenite in drinking water (group II), respectively for eight against the genotoxic effects induced by As in human peripheral months. After eight months, the 25 arsenic-exposed animals lymphocytes. [39] Concurrent exposure to selenite interferes with were divided into five groups of five rats / group and given the the metabolism of arsenite and exacerbates the cytotoxic effects following treatment for 5 consecutive days: of arsenite and its trivalent methylated metabolites in cultured Group IIA -Saline (4 ml/kg orally, once daily) cells. Gregus et al. [40] noted that Se facilitates the excretion of Group IIB -DMSA (0.3 mmol/kg orally, once daily) inorganic As metabolites in rats. Selenium and arsenic each Group IIC -Selenium as sodium selenite (12.6 µmol/kg, i.p, increase the biliary excretion of the other. [41] once daily) We also recently reported that Se administration provided Group IID -DMSA (as in group IIB) + Selenium (6.3 µmol/kg, significant protection to the liver injury caused by As and i.p, once daily) provided more pronounced elimination of As in male rats. [42] Group IIE -DMSA (as in group IIB) + Selenium (12.6 µmol/kg, Badiello et al. [43] recently suggested that the administration i.p, once daily) and δ-aminolevulinic acid (ALA) were procured from Sigma (St. Louis, MO, USA) while sodium selenite was obtained from Merck (Germany). All other analytical laboratory chemicals and reagents were purchased from Merck (Germany), Sigma or BDH Chemicals. Ultra pure water prepared using a Millipore apparatus (Millipore Company, New Delhi, India) was used throughout the experiment to avoid metal contamination and for the preparation of reagents / buffers used for various biochemical assays in our study. DMSA was stored in desiccator at 4°C to avoid oxidation and thermal decomposition and dissolved in 5% sodium bicarbonate solution. Sodium selenite was dissolved in distilled water. Solutions of DMSA and sodium of Se could provide a detoxifying action against metal ions, in addition to its antioxidant action. Thus, adequate or even extra Se in the diet may alleviate As toxicity. It is clear from the above mentioned studies that Se has got a significant role in protecting mice from the toxic effects of arsenite. However, selenium's beneficial role after arsenic exposure or during chelation treatment has not been explored. Thus, the present study was planned to evaluate the therapeutic potential of Se when given in combination with DMSA in depletion of As concentration in blood and other soft tissues postarsenic exposure and in providing recovery in the altered biochemical variables, indicative of oxidative stress organ injury.
Materials and Methods

Chemicals and reagents
Meso-2, 3-dimercaptosuccinic acid (DMSA), sodium arsenite Arsenic exposure was stopped during the course of chelation treatment. A single dose of 0.3 mmol/kg of DMSA and 6.3 and 12.6 µmol/kg doses of Se were selected based on the results from previous experiments. [25, 35] Doses of DMSA and Se were given daily at six hour intervals. The food and water intake was recorded and rats were weighed every week. Forty-eight hours after the administration of the last dose, the animals were sacrificed under light ether anesthesia. Blood was collected by cardiac puncture in heparinized and nonheparinized vials (for serum). Liver, kidneys and brain were removed, rinsed in cold saline, blotted, weighed and used for various biochemical variables and metal analysis. Half portions of the liver and brain and one of the kidneys from all rats were processed immediately for biochemical estimation and the remaining portions were stored at -20 º C before wet acid digestion with HNO for estimation of As and Se concentrations. 
Modi, et al.: Selenium supplementation during chelation of arsenic in rats
Biochemical assay The activity of blood δ-aminolevulinic acid dehydratase (ALAD) was assayed according to the procedure of Berlin and Schaller [44] while white blood cells (WBC), red blood cells (RBC), hematocrit (Hct), hemoglobin (Hb), mean cell volume (MCV), mean cell hemoglobin (MCH) and mean cell hemoglobin concentration (MCHC) were measured by a Sysmex Hematology Analyzer (model K4500). Blood GSH concentration was determined by the procedure described by Ellman [45] and modified by Jollow et al. [46] Liver δ-aminolevulinate synthase (ALAS) activity was measured by the method of Maines [47] while variance followed by Bonferroni test to compare means between the different treatment groups. Differences between unexposed (with or without chelation) with a P value < 0.05 were considered statistically significant.
Results
Effects of Se, DMSA or their combination on as-induced changes in some hematological variables
Exposure to As significantly inhibited blood ALAD activity while marginally (not significantly) decreasing GSH levels. Although Reactive oxygen species (ROS) levels showed a et al.
brain, liver and kidney GSH and GSSG (oxidized GSH) levels significant increase on As exposure, there was no marked were determined as described by Hissin and Hilf [48] using a effect on hemoglobin and hematocrit in As-exposed rats. spectrofluorometer (Model RF 5000 Shimadzu, Japan). For Treatment with DMSA alone reduced ROS levels and resulted the GSSG assay, the procedure described above for the GSH in an increase in blood ALAD activity. Administration of Se (12.6 assay was followed except that 0.1 mol/L NaOH was used as µmol) significantly decreased ROS levels while it had no effect the diluent instead of phosphate buffer.
on any other biochemical variables. Combined administration Tissue SOD activity was assayed by the method of Nisshikimi of Se and DMSA on the other hand, had no additional beneficial [49] and modified by Kakkar et al. [50] while catalase activity effects over the individual effects of DMSA [ Table 1 ]. in tissues was assayed following Sinha's procedure. [51] GPx The effects of As and chelation treatment on a few activity was measured by the procedure of Flohe and Gunzler. [52] additional hematological variables in As-exposed rats were Tissue lipid peroxidation was measured by method of Ohkawa also determined. Chronic As exposure caused significant [53] Amount of ROS in the blood was measured using 2', 7'-decrease in WBC counts however, no statistically significant dichlorofluorescein diacetate (DCF-DA) that gets converted into changes were observed in RBC, MCV, MCH, MCHC and highly fluorescent DCF by cellular peroxides (including hydrogen platelet levels (Data not shown). Except for increased WBC peroxide). Fluorescence was determined at an excitation counts following combined administration of Se (at lower wavelength of 488 nm and an emission wavelength of 525 nm dose) and DMSA, no effect of chelating agent, selenium or using a fluorescence plate reader (Tecan Spectra Fluor Plus). The their concomitant administration was noted on any of these activities of alkaline Phosphatase (ALP) and acid phosphatase hematological variables. (ACP) were determined as described by Fiske and Subbarow. [54] Effects of Se, DMSA or their combination on biochemical Alanine aminotransferase (ALT) and aspartate aminotransferase variables indicative of hepatic oxidative stress (AST) activities were measured in serum and liver. [55] Arsenic exposure led to a significant depletion of hepatic Metal estimation GSH levels and an increase in thiobarbituric acid-reacting Arsenic concentration in blood, liver, kidneys and brain substances (TBARS) levels. Liver ALAD activity also showed were measured after wet acid digestion using a Microwave a significant decrease accompanied by a marked elevation Digestion System (CEM, USA, model MDS-2100). Arsenic in ALAS activity suggesting disturbed porphyrin metabolism. was estimated using a Hydride Vapour Generation System No effect on SOD activity was noted while catalase and GPx (Perkin Elmer model MHS-10) fitted with an atomic absorption activities showed significant decrease. Postarsenic exposure spectrophotometer (AAS, Perkin Elmer model AAnalyst 100). treatment with DMSA provided significant recovery in hepatic Selenium concentration was also measured in the digested TBARS levels and ALAD activity. Administration of Se alone tissue samples using AAS. [56] had no effect on the above biochemical variables although Statistical analysis concomitant administration of Se (at the dose of 6.3 µmol) Data is expressed as mean ± SE (standard error). Data with DMSA was marginally better than monotherapy with the et al.
comparisons were carried out using one way analysis of chelating agent [ Table 2 ]. Table 1 Effects of selenium, DMSA and their combination on arsenic-induced changes in hematological parameters in arsenic-exposed rats Table 3 shows biochemical variables indicative of liver damage. Arsenic exposure caused significant decrease in hepatic ALP and ACP activities while, serum AST and ALT activities showed increases. Treatment with DMSA and Se had no effect on any of these biochemical variables. Table 4 shows the changes in biochemical variables suggestive of renal oxidative stress in As-exposed rats treated with DMSA alone or in combination with Se. There was a significant increase in TBARS levels accompanied by a decreased catalase activity in kidneys of As-exposed animals. Renal GSH, GSSG levels and SOD activities remained unaltered on As exposure. Treatments with Se and DMSA alone were able to significantly reduce the increases in TBARS levels while no beneficial effect on catalase activity was observed. Concomitant administration of Se also had no additional beneficial effects over the effect of monotherapy with DMSA.
Effects of Se, DMSA or their combination on biochemical variables indicative on renal oxidative stress
Effects of Se, DMSA or their combination on biochemical variables indicative of brain oxidative stress
Brain GSH showed significant depletion while GSSG, GPx and SOD activities remained unchanged and brain TBARS level increased significantly on arsenic exposure. Treatment in TBARS levels while no effects on other brain biochemical variables were observed [ Table 5 ].
Effects of Se, DMSA or their combination on arsenic concentration
1.2
The increased As concentration in blood, liver and kidneys was significantly reduced by DMSA except for brain As levels which did not show any significant depletion [ Figure 1 ]. Administration of Se alone had no effect on As concentrations Figure 2 ]. Administration of Se either alone or in combination with DMSA led to a significant increase in Se concentrations in these organs.
Discussion
The data from the present study provides a few interesting observations concerning the effects of Se during chelation treatment with DMSA in providing better recovery in Assensitive, altered biochemical and clinical variables compared to the individual effects of Se and DMSA. Such variables are indicative of oxidative stress, organ damage and altered heme synthesis pathway and mobilization of As from blood and other soft tissues of arsenic-exposed rats. It is evident from the results of the present investigation that administration of Se particularly at a dose of 6.3 µmol/kg of body weight with DMSA can lead to a more pronounced decrease in the liver and kidney levels of As and provided significant restoration of As-induced oxidative stress than monotherapy with DMSA.
Recent studies have suggested that As toxicity is associated with the induction of oxidative stress through the excessive generation of ROS and the inhibition of antioxidant enzymes. ROS include hydrogen peroxide and free radicals such as hydroxyl radical, superoxide anion, dimethyl arsenic peroxy and dimethylarsinic radicals in living systems.
[11-13,20,57] The result of the present work shows increased ROS generation in blood which also supports this hypothesis. In addition, sodium arsenite has been shown to enhance heme oxygenase production, an indicator of oxidative stress. [17] In the present study, exposure to As led to a significant depletion of GSH in the blood and liver. GSH is a critical component of the oxidant defense system which helps in scavenging free radicals generated during As poisoning. [58] GSH depletion may be responsible for the accumulation of free radicals that initiate lipid peroxidation (LPO) resulting in biochemical damage after covalent binding to biomacromolecules. GSH also protects the membrane polyunsaturated fatty acids from peroxidation and has an antioxidant function. [59] GSH depletion also impairs hepatobiliary transport of arsenite [60] as the lack of GSH prevents conversion of the trivalent arsenicals into labile GSH conjugates namely arsenotriglutathione [As(GSH) 3 ]. This conjugate is a the oxidation of GSH. Depression of GPx activity was observed in the liver of As-exposed animals. Decrease in the activity of GPx during As treatment indicates the reduction in the levels of GSH and increase in the levels of peroxides. The decreased acivity of GPx after As intoxication may arise because Se is a cofactor for GPx and As interacts with the essential selenocysteine moiety of the enzyme.
[68] Inhibition of antioxidant enzymes, viz., catalase and GPx in As-exposed animals also point to a disturbed antioxidant defence system of cells which might lead to generation of oxidative stress. Inorganic As compounds are known to be hepatotoxic. The determination of the activities complex in which arsenic is bound to the thiol moieties of the of pathological enzymes like transaminases (AST and ALT) and cysteinyl residues of three GSH molecules. As(GSH) 3 acts as a phosphatases (ALP and ACP) is a common means of detecting substrate for mrp-2, a primary active transporter in the bile liver damage. A significant decrease in hepatic ACP and ALP canalicular membrane. [61] activities and a significant elevation of AST and ALT activities In addition, the oxidized form of hepatic GSH (GSSG) showed in serum without any significant change in serum ALP activity a marginal increase (nonsignificant) in rats exposed to As.
was noted following As exposure. Increased formation of GSSG would be expected to increase
The current therapeutic approach to As poisoning is to production of hydrogen peroxide via GPx activity.
increase the excretion of As by chelation. DMSA, a vicinal dithiol A significant inhibition of blood and liver ALAD activity was chelator has been reported to be effective in reducing lethality noted while ALAS activity increased in the liver of As-exposed and chronic As toxicity in laboratory animals. [69] It interacts with rats. ALAD is the key enzyme that catalyzes the second step As in the cell forming a saturated five membered heterocyclic in heme biosynthesis in which two molecules of ALA are ring namely 1, 3-dithiol-2-arsolan. DMSA decreases the As transformed into prophobilinogen, a heme precursor.
[62] The burden in the cells by inhibiting the continuous production of activity of ALAD is highly sensitive to the toxic effects of As. [63] ROS. [26] In our study, we observed that DMSA alone marginally ALAD possesses thiol groups, which are essential for its activity.
effected the inhibition of ALAD activity, significantly increased The diminished activity of ALAD as a result of As exposure could blood GSH levels, depleted TBARS in the liver and kidney and be caused by interference of As with the thiol groups resulting reduced ROS levels in blood. There was also a significant in the accumulation of ALA.
[64] Stimulation of ALAS activity also depletion of blood and soft tissue (liver and kidneys) As leads to increased ALA production and urinary excretion.
concentrations on DMSA administration. This could thus be Earlier studies suggest that ROS produced due to ALA attributed to the possibility that DMSA alone might be providing accumulation leads to the generation of oxidative stress some recovery in biochemical variables indicative of oxidative and DNA damage.
[65] Inhibition of ALAD activity by As led to stress by removing the As from the target organ and / or directly decreased heme synthesis and ultimately anemia. In the present scavenging ROS via its sulfhydryl groups.
[68] study, As exposure produced a nonsignificant reduction of It is plausible that impaired oxidant / antioxidant balance hemoglobin and a significant decrease in WBC counts which can be responsible for the toxic effect of As, hence, a therapeutic are in agreement with previous reports.
[66] This might be due strategy to increase the antioxidant capacity of the cell is to bone marrow depression following chronic exposure to As. required to enhance the long-term effective treatment of As The results also demonstrate that As induced a significant poisoning. It is well known that chelation therapy with many increase in lipid peroxidation (increased TBARS levels), a synthetic chelating agents is compromised with a number of basic cellular process of deterioration of polyunsaturated fatty side effects. [70] A number of strategies have been suggested to acids and occurs readily in the tissues rich in highly oxidizable minimize the numerous problems associated with chelation polyunsaturated fatty acids. [67] therapy. One of the important approaches has been the use of It is speculated that the increased lipid peroxidation is a result of the impairment of the endogenous antioxidant system by As and could be directly related to GSH depletion. The increase in lipid peroxidation was accompanied by a concomitant decrease in the antioxidant enzymes such as catalase, SOD and GPx. SOD and catalase are considered primary enzymes since they are involved in the direct elimination of ROS. [67] SOD is an important defence enzyme, which catalyzes the dismutation of superoxide radicals (O 2 . -to H 2 O 2 ). Catalase is a heme protein, which catalyzes the reduction of hydrogen peroxides (converts H 2 O 2 to oxygen and water) and protects tissues from highly reactive hydroxyl radicals. In the present study, catalase activity was reduced significantly in the liver and kidneys of As-exposed rats which could be due to the accumulation of superoxide anion radicals and hydrogen peroxide.
GPx, a Se-containing enzyme detoxifies H 2 O 2 to H 2 O through combination therapy. [69] This prompted us to explore whether the co-administration of an antioxidant nutrient like Se during the removal of As by a a chelating agent could provide any additional advantage, i.e., abatement of the toxic effects of As. In the body, there are a number of Se-dependent activities involved in counteracting the toxicity of elements like As as well as the carcinogenicity of known as well as unknown chemical substances. The protective value of Se against oxidative injury is well known. [34, 38] Dimitrov et al. [71] reported that Se is important in sulphur-containing amino acid metabolism.
Sulphur-containing amino acids protect animals against several diseases associated with low intake of Se and vitamin E. In this way, the sulphur-containing amino acids-methionine and cysteine can spare Se for antioxidant role. Selenium also maintains the levels of antioxidants, membrane-bound enzymes and the activities of antioxidant enzymes near normal levels thus, emphasizing their effects as antioxidants. Most studies so far have investigated the As-Se interaction to study its fate and biological activity [40, 72] while its effects when given in combination with a chelating agent postarsenic exposure have not been studied so far. The result of the present work showed that Se administration during chelation of As with DMSA affected the efficiency of the chelating agent in providing better reversal in a few altered biochemical variables. This was seen particularly in the reduction of As-induced oxidative stress and an effective removal of As from the liver and kidneys of Asexposed animals as compared to the individual effects of DMSA.
However, there were other prominent beneficial effects on ) .
